Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Arantxa Gonzalez

Has grant

Director

Universidad de Navarra

Spain

Research Interests

Explore related searches

Professors in Spain

Recent Grants

Grant: Close

Estudio prospectivo, aleatorizado, multicéntrico, abierto, (con análisis ciego de eventos) para evaluar la no inferioridad de una estratégia personalizada de precisión para la prevención de la muerte súbita em pacientes con miocardiopatía dilatada no isquémica.

Open Date: 2022-01-01

Close Date: 2025-01-01

Grant: Close

Personalized Assessment of CardioEmbolic Risk – 1 (PACER-1).

Open Date: 2022-01-01

Close Date: 2024-01-01

Grant: Close

Estudio genómico para la personalización del diagnóstico y el tratamiento de los pacientes con insuficiencia cardíaca crónica y enfermedad renal crónica-II (Medicina cardiorrenal pERsonalizada en NaVArra -II)

Open Date: 2021-01-01

Close Date: 2023-01-01

Grant: Close

Estudio prospectivo, multicéntrico y abierto para evaluar la eficacia del esmolol en la identificación precoz de las alteraciones cardiovasculares inducidas por la cirrosis, la diabetes mellitus y los tratamientos cardiotóxicos (bB-ECHO)

Open Date: 2021-01-01

Close Date: 2025-01-01

Grant: Close

MiCrovasculaR rarefaction in vascUlar Cognitive Impairment and heArt faiLure (CRUCIAL)

Open Date: 2020-01-01

Close Date: 2024-01-01

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Collaborators (24)

Fardad Soltani

The University of Manchester

UNITED KINGDOM

Arantxa Gonzalez

Research Interests

Explore related searches

Recent Grants

Articles (20)

Microcurrent Therapy in Cardiac Repair: Bridging Mechanistic Biology and Clinical Evidence

An expert opinion on heart failure in hypertensive heart disease

Repaired tetralogy of Fallot: characterization of myocardial fibrosis by magnetic resonance imaging

Cardiac fibroblasts in myocardial injury and heart failure

Effect of pirfenidone on plasma markers of collagen turnover in patients with heart failure, preserved left ventricular ejection fraction and myocardial fibrosis

Two concurrent mechanisms are responsible for the INa increase produced by dapagliflozin and empagliflozin in healthy and heart failure cardiomyocytes

Myocardial Remodelling in Aortic Regurgitation: Time to Think Beyond Volumes and Function?

Circulating collagen type I fragments as specific biomarkers of cardiovascular outcome risk: Where are the opportunities?

State of the art and perspectives of gene therapy in heart failure. A scientific statement of the Heart Failure Association of the ESC, the ESC Council on Cardiovascular Genomics and the ESC Working Group on Myocardial & Pericardial Diseases

Update on preclinical models of cancer therapy-related cardiac dysfunction: Challenges and perspectives. A scientific statement of the Heart Failure Association (HFA) of the ESC, the ESC Council of Cardio-Oncology, and the ESC Working Group on Cellular Biology of the Heart

Exercise-induced biomolecular changes and cardiovascular effects in heart failure: a systematic review and meta-analysis

Echocardiographic and biomarker characteristics in diabetes, coronary artery disease or both: insights from HOMAGE trial

Generation of Self-Induced Myocardial Ischemia in Large-Sized Cardiac Spheroids without Alteration of Environmental Conditions Recreates Fibrotic Remodeling and Tissue Stiffening Revealed by Constriction Assays

Effects of spironolactone on exercise blood pressure in patients at increased risk of developing heart failure: report from the HOMAGE trial

Myocardial fibrosis from the perspective of the extracellular matrix: Mechanisms to clinical impact

Circulating biomarkers of myocardial remodelling: current developments and clinical applications

Integration of implantable device therapy in patients with heart failure. A clinical consensus statement from the Heart Failure Association (HFA) and European Heart Rhythm Association (EHRA) of the European Society of Cardiology

Myocardial perfusion in cardiac amyloidosis

High variability in assays of blood markers of collagen turnover in cardiovascular disease: Implications for research and clinical practice

Myocardial Interstitial Fibrosis in Hypertensive Heart Disease: From Mechanisms to Clinical Management

Collaborators (24)

Fardad Soltani

Ida Gjervold Lunde

Javier Díez

Blanca Gordon Ramírez

Margarida Serra

MU Moreno

Robinson Ramírez‐Vélez

james moon

Rob MacLeod

Michael Mc Kenna

Pedro Vicente

Jesús Ciriza

Pierpaolo Pellicori

Thilo Burkard

Dagfinn Aune

Thomas Treibel

J. Eduardo Rame

Joan Chang

Federica Genovese

Javed Butler

Ricardo Gómez

Konstantinos Stellos

George Thornton

Marat Fudim

Make your next move.